Pelthos Therapeutics (PTHS) Common Equity (2022 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Common Equity of $38.9 million for Q4 2025, up 1532.61% year-over-year from $2.4 million in Q4 2024, and down 33.25% quarter-over-quarter from $58.3 million in Q3 2025.
Pelthos Therapeutics (PTHS) Common Equity (2022 - 2026) Analysis & Trends
Pelthos Therapeutics' Common Equity history runs 4 years deep, the most recent figure standing at $38.9 million for Q4 2025.
- In Q4 2025, Common Equity rose 1532.61% year-over-year to $38.9 million; the TTM figure through Dec 2025 stood at $38.9 million (up 1532.61% YoY), while the FY2025 annual figure was $38.9 million, up 1532.61% from the prior year.
- Common Equity for Q4 2025 stood at $38.9 million, down from $58.3 million in the prior quarter.
- The five-year high for Common Equity was $58.3 million in Q3 2025, with the low at -$6.5 million in Q2 2025.
- The 4-year median for Common Equity is -$3.7 million (2022), against an average of $4.5 million.
- Peak annual rise in Common Equity reached 4179.34% in 2025, while the deepest fall reached 3429.35% in 2025.
- Pelthos Therapeutics' Common Equity stood at -$3.7 million in 2022, then sank by 73.88% to -$6.4 million in 2023, then surged by 57.89% to -$2.7 million in 2024, then jumped by 1532.61% to $38.9 million in 2025.
- Business Quant data shows PTHS's Common Equity at $38.9 million in Q4 2025, $58.3 million in Q3 2025, and -$6.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.76 Bn | 130.91 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.15 Bn | 78.15 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.45 Bn | 59.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.08 Bn | 51.94 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.90 Bn | 27.59 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 27.76 Bn | 9.37 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - | 9.79 Bn |
| 10 | Pelthos Therapeutics | 93.97 Mn | 69.41 Mn | 21.23 Mn | -1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.50 Mn |
| Dec 31, 2025 | 38.88 Mn |
| Sep 30, 2025 | 58.25 Mn |
| Jun 30, 2025 | -6.49 Mn |
| Mar 31, 2025 | -4.20 Mn |
| Dec 31, 2024 | -2.71 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -184,000.00 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | -6.45 Mn |
| Sep 30, 2023 | -5.90 Mn |
| Jun 30, 2023 | -4.90 Mn |
| Mar 31, 2023 | -4.44 Mn |
| Dec 31, 2022 | -3.71 Mn |